Cargando…
Metallothionein 3 Expression in Normal Skin and Malignant Skin Lesions
Metallothionein-3 (MT-3) has been shown to be expressed in several malignancies and to have an impact on patients’ survival in breast and urinary bladder cancer cases. However, its expression has not been determined in normal skin or in its malignant lesions. MT-3 expression was studied using immuno...
Autores principales: | Pula, Bartosz, Tazbierski, Tadeusz, Zamirska, Aleksandra, Werynska, Bozena, Bieniek, Andrzej, Szepietowski, Jacek, Rys, Janusz, Dziegiel, Piotr, Podhorska-Okolow, Marzena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287679/ https://www.ncbi.nlm.nih.gov/pubmed/25015776 http://dx.doi.org/10.1007/s12253-014-9805-7 |
Ejemplares similares
-
Role of metallothioneins in benign and malignant thyroid lesions
por: Pula, Bartosz, et al.
Publicado: (2012) -
Angiotensin II Type 1 Receptor (AT-1R) Expression Correlates with VEGF-A and VEGF-D Expression in Invasive Ductal Breast Cancer
por: Jethon, Aleksandra, et al.
Publicado: (2012) -
Metallothionein-3 Increases Triple-Negative Breast Cancer Cell Invasiveness via Induction of Metalloproteinase Expression
por: Kmiecik, Alicja M., et al.
Publicado: (2015) -
Expression of Metallothioneins in Cutaneous Squamous Cell Carcinoma and Actinic Keratosis
por: Zamirska, Aleksandra, et al.
Publicado: (2012) -
Role of tesmin expression in non-small cell lung cancer
por: Grzegrzolka, Jedrzej, et al.
Publicado: (2021)